Arout, C. A., Haney, M., Herrmann, E. S., Bedi, G., & Cooper, Z. D. (2021). A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans. British Journal of Clinical Pharmacology, 88(1), 347–355. https://doi.org/10.1111/bcp.14973
Baswan, S. M., Klosner, A. E., Glynn, K., Rajgopal, A., Malik, K., Yim, S., & Stern, N. (2020). Therapeutic potential of cannabidiol (CBD) for skin health and disorders. Clinical, Cosmetic and Investigational Dermatology, Volume 13, 927–942. https://doi.org/10.2147/ccid.s286411
Burstein, S. (2015). Cannabidiol (CBD) and its analogs: A review of their effects on inflammation. Bioorganic & Medicinal Chemistry, 23(7), 1377–1385. https://doi.org/10.1016/j.bmc.2015.01.059
Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006). Inhibition of an equilibrative nucleoside transporter by Cannabidiol: A mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences, 103(20), 7895–7900. https://doi.org/10.1073/pnas.0511232103
Cuñetti, L., Manzo, L., Peyraube, R., Arnaiz, J., Curi, L., & Orihuela, S. (2018). Chronic pain treatment with cannabidiol in kidney transplant patients in Uruguay. Transplantation Proceedings, 50(2), 461–464. https://doi.org/10.1016/j.transproceed.2017.12.042
Darkovska-Serafimovska, M., Serafimovska, T., Arsova-Sarafinovska, Z., Stefanoski, S., Keskovski, Z., & Balkanov, T. (2018). Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases. Journal of Pain Research, Volume 11, 837–842. https://doi.org/10.2147/jpr.s160556
De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., Petrosino, S., Stott, C. G., & Di Marzo, V. (2011). Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. British Journal of Pharmacology, 163(7), 1479–1494. https://doi.org/10.1111/j.1476-5381.2010.01166.x
Fitzcharles, M. A., Clauw, D. J., & Hauser, W. (2020). A cautious hope for Cannabidiol (CBD) in rheumatology care. Arthritis Care & Research. https://doi.org/10.1002/acr.24176
Hammell, D. C., Zhang, L. P., Ma, F., Abshire, S. M., McIlwrath, S. L., Stinchcomb, A. L., & Westlund, K. N. (2015). Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. European Journal of Pain, 20(6), 936–948. https://doi.org/10.1002/ejp.818
Kotschenreuther, K., Waqué, I., Yan, S., Meyer, A., Haak, T., von Tresckow, J., Schiller, J., Gloyer, L., Dittrich-Salamon, M., & Kofler, D. M. (2020). Cannabinoids drive th17 cell differentiation in patients with rheumatic autoimmune diseases. Cellular & Molecular Immunology, 18(3), 764–766. https://doi.org/10.1038/s41423-020-0437-4
Lindstedt, F., Karshikoff, B., Schalling, M., Olgart Höglund, C., Ingvar, M., Lekander, M., & Kosek, E. (2012). Serotonin-1A receptor polymorphism (RS6295) associated with thermal pain perception. PLoS ONE, 7(8). https://doi.org/10.1371/journal.pone.0043221
Lowin, T., Tingting, R., Zurmahr, J., Classen, T., Schneider, M., & Pongratz, G. (2020). Cannabidiol (CBD): A killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death & Disease, 11(8). https://doi.org/10.1038/s41419-020-02892-1
Khaleghi, M. (2020). New arthritis foundation guidelines on CBD use could be first of many more to come. Alternative therapies in health and medicine. Retrieved May 9, 2022, from https://pubmed.ncbi.nlm.nih.gov/32035005/
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000). The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences, 97(17), 9561–9566. https://doi.org/10.1073/pnas.160105897
McPartland, J. M., & Russo, E. B. (2001). Cannabis and cannabis extracts. Journal of Cannabis Therapeutics, 1(3-4), 103–132. https://doi.org/10.1300/j175v01n03_08
Miller , R. J., & Miller, R. E. (2017). Is cannabis an effective treatment for joint pain? Clinical and experimental rheumatology. Retrieved May 9, 2022, from https://pubmed.ncbi.nlm.nih.gov/28967368/
Pathak, N., Radford, Z. J., Kahan, J. B., Grauer, J. N., & Rubin, L. E. (2022). Publication frequency and google trends analysis of popular alternative treatments to arthritis. Arthroplasty Today, 14, 76–80. https://doi.org/10.1016/j.artd.2021.12.009
Philpott, H. T., O'Brien, M., & McDougall, J. J. (2017). Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis. Pain, 158(12), 2442–2451. https://doi.org/10.1097/j.pain.0000000000001052
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005). Agonistic properties of cannabidiol at 5-HT1A receptors. Neurochemical Research, 30(8), 1037–1043. https://doi.org/10.1007/s11064-005-6978-1
Silmore, L. H., Willmer, A. R., Capparelli, E. V., & Rosania, G. R. (2021). Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of Clinical Studies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 41(4), 405–420. https://doi.org/10.1002/phar.2512
Vela, J., Dreyer, L., Petersen, K. K., Arendt-Nielsen, L., Duch, K. S., & Kristensen, S. (2021). Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: A randomized, double-blind, placebo-controlled trial. Pain, Publish Ahead of Print. https://doi.org/10.1097/j.pain.0000000000002466
Watkins, A. R. (2019). Cannabinoid interactions with ion channels and receptors. Channels, 13(1), 162–167. https://doi.org/10.1080/19336950.2019.1615824
Xiong, W., Cui, T., Cheng, K., Yang, F., Chen, S.-R., Willenbring, D., Guan, Y., Pan, H.-L., Ren, K., Xu, Y., & Zhang, L. (2012). Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. Journal of Experimental Medicine, 209(6), 1121–1134. https://doi.org/10.1084/jem.20120242